Leonard Frank X

Insider Reports History

Entity
Individual
Location
20 Valley Stream Parkway,, Suite 300, Malvern, PA
Signature
Ovie Onobrakpeya, as attorney in fact for Leonard, Frank X.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Leonard Frank X:

Stock Role Class Num Shares Value Price $ Report Date Ownership
NovoCure Ltd EVP, Pres., Novocure Oncology Ordinary Shares 161K $2.57M $15.94 Nov 1, 2024 Direct
NovoCure Ltd EVP, Pres., Novocure Oncology Stock Options (Right to buy) 156K $2.55M $16.30 Feb 27, 2024 Direct
NovoCure Ltd EVP, Pres., Novocure Oncology Restricted Share Units 6.21K Jan 4, 2024 Direct

Insider Reports Filed by Leonard Frank X

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NVCR NovoCure Ltd Nov 1, 2024 1 -$9.53K 4 Nov 4, 2024 EVP, Pres., Novocure Oncology
NVCR NovoCure Ltd Jun 28, 2024 1 $21.2K 4 Aug 6, 2024 EVP, Pres., Novocure Oncology
NVCR NovoCure Ltd Mar 1, 2024 2 -$40.4K 4 Mar 5, 2024 EVP, Pres., Novocure Oncology
NVCR NovoCure Ltd Feb 27, 2024 3 $4.18M 4 Feb 29, 2024 EVP, Pres., Novocure Oncology
NVCR NovoCure Ltd Jan 4, 2024 0 $0 3 Jan 12, 2024 EVP, Pres., Novocure Oncology
NVCR NovoCure Ltd Mar 3, 2023 4 -$1.03M 4 Mar 7, 2023 President, CNS Cancers US
NVCR NovoCure Ltd Mar 2, 2023 3 -$223K 4 Mar 6, 2023 President, CNS Cancers US
NVCR NovoCure Ltd Mar 2, 2023 2 -$310K 4 Mar 3, 2023 President, CNS Cancers US
NVCR NovoCure Ltd Feb 28, 2023 3 $2.26M 4 Mar 2, 2023 President, CNS Cancers US
NVCR NovoCure Ltd Jan 5, 2023 19 -$3.89M 4 Jan 9, 2023 President, CNS Cancers US
NVCR NovoCure Ltd Nov 1, 2022 2 $850K 4 Nov 3, 2022 President, CNS Cancers US
NVCR NovoCure Ltd Oct 13, 2022 1 -$513K 4 Oct 17, 2022 President, CNS Cancers US
NVCR NovoCure Ltd Oct 6, 2022 1 -$570K 4 Oct 7, 2022 President, CNS Cancers US
NVCR NovoCure Ltd Sep 29, 2022 1 -$522K 4 Sep 30, 2022 President, CNS Cancers US
NVCR NovoCure Ltd Sep 22, 2022 1 -$520K 4 Sep 26, 2022 President, CNS Cancers US
NVCR NovoCure Ltd Sep 15, 2022 4 -$1.05M 4 Sep 19, 2022 Chief Development Officer
NVCR NovoCure Ltd Sep 9, 2022 1 -$164K 4 Sep 12, 2022 Chief Development Officer
NVCR NovoCure Ltd Sep 8, 2022 1 -$550K 4/A Sep 13, 2022 Chief Development Officer
NVCR NovoCure Ltd Sep 6, 2022 1 -$109K 4 Sep 7, 2022 Chief Development Officer
NVCR NovoCure Ltd Sep 1, 2022 13 -$1.15M 4 Sep 6, 2022 Chief Development Officer
NVCR NovoCure Ltd Aug 2, 2022 1 -$28.8K 4 Aug 3, 2022 Chief Development Officer
NVCR NovoCure Ltd Jul 5, 2022 1 $18.4K 4 Jul 7, 2022 Chief Development Officer
NVCR NovoCure Ltd Mar 8, 2022 1 -$52.2K 4 Mar 9, 2022 Chief Development Officer
NVCR NovoCure Ltd Mar 3, 2022 5 $2.74M 4 Mar 7, 2022 Chief Development Officer
NVCR NovoCure Ltd Sep 2, 2021 1 -$74.6K 4 Sep 7, 2021 Chief Development Officer
NVCR NovoCure Ltd Aug 2, 2021 2 -$156K 4 Aug 4, 2021 Chief Development Officer
NVCR NovoCure Ltd Jul 6, 2021 1 $21.1K 4 Jul 8, 2021 Chief Development Officer